Patient Guide: A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 24 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05926960
Status: ACTIVE_NOT_RECRUITING
Condition: Melanoma
Phase: PHASE2

Where You Can Participate

This study is available at 24 locations across the country.

Top locations include:
  • • Tübingen, Baden-württemberg
  • • Hannover, Niedersachsen
  • • Essen, Nordrhein-westfalen
  • • And 21 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma - Join Clinical Trial NCTNCT05926960

How to Join This Clinical Trial - NCTNCT05926960

Learn how to participate in this PHASE2 trial studying an investigational therapy for Melanoma. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Melanoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Melanoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05926960 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 24 locations. Find a study site near you:

Clinical Research Site

Tübingen, Baden-württemberg 72076 - Germany

Status: Contact for availability

Clinical Research Site

Hannover, Niedersachsen 30625 - Germany

Status: Contact for availability

Clinical Research Site

Essen, Nordrhein-westfalen 45147 - Germany

Status: Contact for availability

Clinical Research Site

Münster, Nordrhein-westfalen 48157 - Germany

Status: Contact for availability

Clinical Research Site

Mainz, Rheinland-pfalz 55131 - Germany

Status: Contact for availability

Clinical Research Site

Lübeck, Schleswig-holstein 23538 - Germany

Status: Contact for availability

Clinical Research Site

Rome, Roma 00144 - Italy

Status: Contact for availability

Clinical Research Site

Palermo, Sicilia 90127 - Italy

Status: Contact for availability

Clinical Research Site

Candiolo, Torino 10060 - Italy

Status: Contact for availability

Clinical Research Site

Siena, Toscana 53100 - Italy

Status: Contact for availability

And 14 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Melanoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships